Cargando…

Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial

Background: To investigate whole-body contrast-enhanced CT and hepatobiliary contrast liver MRI for the detection of extrahepatic disease (EHD) in hepatocellular carcinoma (HCC) and to quantify the impact of EHD on therapy decision. Methods: In this post-hoc analysis of the prospective phase II open...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geyer, Thomas, Kazmierczak, Philipp M., Steffen, Ingo G., Malfertheiner, Peter, Peynircioglu, Bora, Loewe, Christian, van Delden, Otto, Vandecaveye, Vincent, Gebauer, Bernhard, Pech, Maciej, Sengel, Christian, Bargellini, Irene, Iezzi, Roberto, Benito, Alberto, Zech, Christoph J., Gasbarrini, Antonio, Schütte, Kerstin, Ricke, Jens, Seidensticker, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139039/ https://www.ncbi.nlm.nih.gov/pubmed/35625900 http://dx.doi.org/10.3390/biomedicines10051156

Ejemplares similares

Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
por: Surov, Alexey, et al.
Publicado: (2023)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
por: Öcal, Osman, et al.
Publicado: (2022)

Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort
por: Seidensticker, Max, et al.
Publicado: (2022)

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
por: Öcal, Osman, et al.
Publicado: (2021)

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
por: Öcal, Osman, et al.
Publicado: (2022)

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
por: Seidensticker, Max, et al.
Publicado: (2023)

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
por: Öcal, Osman, et al.
Publicado: (2022)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients
por: Saalfeld, Sylvia, et al.
Publicado: (2023)

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2019)

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial
por: Shuen, Timothy Wai Ho, et al.
Publicado: (2022)

NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2021)

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021)

Reproducibility of CT-Based Hepatocellular Carcinoma Radiomic Features across Different Contrast Imaging Phases: A Proof of Concept on SORAMIC Trial Data
por: Ibrahim, Abdalla, et al.
Publicado: (2021)

Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma
por: Seidensticker, Ricarda, et al.
Publicado: (2016)

Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes
por: Seidensticker, Max, et al.
Publicado: (2011)

Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
por: Seidensticker, Ricarda, et al.
Publicado: (2018)

Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial
por: Damm, Robert, et al.
Publicado: (2023)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

Improvement of Contrast Media Enhancement in CTA Evaluating Pulmonary Embolism by Utilizing ‘Delayed’ Bolus Tracking in the Descending Aorta
por: Damm, Robert, et al.
Publicado: (2016)

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
por: Schütte, Kerstin, et al.
Publicado: (2014)

Optimized visualization of focal liver lesions and vascular structures in real-time T1-weighted gradient echo sequences for magnetic resonance-guided liver procedures
por: Schmidt, Vanessa Franziska, et al.
Publicado: (2023)

Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity
por: Seidensticker, Max, et al.
Publicado: (2014)

Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases
por: Damm, Robert, et al.
Publicado: (2022)

Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases
por: Seidensticker, Max, et al.
Publicado: (2010)

Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience
por: Drewes, Ralph, et al.
Publicado: (2019)

Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system
por: Damm, Robert, et al.
Publicado: (2016)

Artifact reduction of coaxial needles in magnetic resonance imaging-guided abdominal interventions at 1.5 T: a phantom study
por: Schmidt, Vanessa Franziska, et al.
Publicado: (2021)

The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond
por: Schulz, Christian, et al.
Publicado: (2019)

Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases
por: Rühl, Ricarda, et al.
Publicado: (2010)

Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma
por: Omari, Jazan, et al.
Publicado: (2018)

In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction (192)Ir high-dose-rate brachytherapy
por: Lüdemann, Lutz, et al.
Publicado: (2011)

The Impact of Unilateral (90)Y-radioembolization on Functional Changes in the Contralateral Hepatic Lobe: The Prospective, Open-label RadioEmbolization, Volumetry, and Liver FuncTion Measurements (REVoluTion) Study
por: Garlipp, Benjamin, et al.
Publicado: (2021)

HCV Extrahepatic Manifestations
por: Kuna, Lucija, et al.
Publicado: (2019)

Extrahepatic pseudocyst in an adult
por: Chen, Yi-An, et al.
Publicado: (2021)

Extrahepatic metabolism of ibrutinib
por: Rood, Johannes J. M., et al.
Publicado: (2020)

Resection of extrahepatic bile ducts with partial hepatectomy for treating intra- and extrahepatic hepatolithiasis
por: Xia, HongTian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b7t3okb014na1v1fe3k6c1cjsr